Establishment Labs Holdings Inc. (ESTA) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Establishment Labs Holdings Inc. (ESTA:NASDAQ), powered by AI.

Current Price
$82.14
P/E Ratio
-47.6
Market Cap
2.4B
Sector
Healthcare
What is the Establishment Labs Holdings Inc. stock price forecast?

Establishment Labs Holdings Inc. is currently trading at $82.14. View real-time AI analysis on Alpha Lenz.

What is Establishment Labs Holdings Inc. insider trading activity?

View the latest insider trading data for Establishment Labs Holdings Inc. on Alpha Lenz.

What is Establishment Labs Holdings Inc.'s P/E ratio?

Establishment Labs Holdings Inc.'s P/E ratio is -47.6.

Establishment Labs Holdings Inc.

NASDAQ · ESTA
$82.14-2.97(-3.49%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Establishment Labs Holdings Inc.'s future dividend policy...
Alpha Chat Insight

Establishment Labs Holdings Inc. trades at a P/E of -47.6 (undervalued) with modest ROE of -133.3%.

Ask for details

Company Overview

Establishment Labs Holdings Inc. is a medical technology company engaged in the design, development, manufacturing, and marketing of innovative breast implants and body shaping products. The company's main purpose is to advance aesthetics and reconstruction surgeries by providing safe, effective, and high-quality medical devices. Establishment Labs operates notably within the healthcare industry, impacting sectors such as cosmetic surgery, reconstructive surgery, and healthcare innovation. The company offers proprietary features including its use of state-of-the-art Motiva Implants, which are known for their enhanced silicone gel properties and advanced surface technology aimed at reducing complications and enhancing patient satisfaction. Headquartered in Alajuela, Costa Rica, Establishment Labs has established a significant presence in the global market, particularly in Latin America, Europe, and Asia, through its extensive distribution network. It plays a crucial role in setting new standards for patient safety and aesthetic outcomes within the plastic surgery realm, contributing to the medical technology industry's growth and evolution.

CEOMr. Fillipo Peter Caldini
SectorHealthcare
IndustryMedical Devices
Employees1,056

Company Statistics

FY 2025

Profile

$2.43BMarket Cap
$211.08MRevenue
0.00Shares Out
1,056Employees

Margins

69.32%Gross
-10.56%EBITDA
-18.48%Operating
-27.49%Pre-Tax
-24.19%Net

Valuation

-47.65P/E
103.32P/B
11.53EV/Sales
-117.62EV/EBITDA
-42.23P/FCF

Growth (CAGR)

9.29%Rev 3Yr
20.04%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-14.51%ROA
-133.25%ROE
-9.31%ROIC

Financial Health

$75.57MCash & Cash Equivalents
$258.05MNet Debt
1416.83%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Establishment Labs Holdings Inc. (ticker: ESTA) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 1,056 employees. Market cap is $2.4B.

The current price is $82.14 with a P/E ratio of -47.65x and P/B of 103.32x.

ROE is -133.25% and operating margin is -18.48%. Annual revenue is $211M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Establishment Labs Holdings Inc. (ESTA) Stock Forecast 2026 $82.14 — Price, Financials & Analyst Targets | Alpha Lenz